Key Financial’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Other funds holding BMRN
Key Financial's BMRN Position: Q3 2026 in Review
Key Financial held its BioMarin Pharmaceuticals (BMRN) position steady in Q3 2026 at 9 shares worth $540. The position accounts for ﹤0.01% of the portfolio, ranked #1222.
Key Financial first reported a position in BMRN in Q4 2020 and has held it in 24 quarters since. The position peaked at $9K in Q4 2020. 434 funds tracked by Wall St. Rank hold BMRN as of Q3 2026.
- Key Financial held 9 shares of BioMarin Pharmaceuticals worth $540 as of Q3 2026.
- Key Financial left its BioMarin Pharmaceuticals share count unchanged in Q3 2026.
- BioMarin Pharmaceuticals made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1222 holding.
- Key Financial first reported a position in BioMarin Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
- Key Financial's BioMarin Pharmaceuticals position peaked at $9K in Q4 2020.
- 434 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.